Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperparathyroidism.

R Udelsman1

  • 1Department of Surgery, Yale University, 330 Cedar Street, FMB102, New Haven, CT 06520, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism diagnosis requires biochemical confirmation. Surgical resection is the recommended treatment due to its high success rate and low morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parathyroid, Thyroid and Recurrent Laryngeal Nerve Anatomy in an Indian Rhinoceros (Rhinoceros unicornis).

World journal of surgery·2017
Same author

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors.

Oncology reports·2011
Same author

Parathyroid surgery in familial hyperparathyroid disorders.

Journal of internal medicine·2004
Same author

BRAF T1796A transversion mutation in various thyroid neoplasms.

The Journal of clinical endocrinology and metabolism·2004
Same author

Minimally invasive parathyroid surgery.

Minerva chirurgica·2002
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism (PHP) is characterized by elevated serum calcium and parathyroid hormone levels.
  • Current non-surgical treatments offer limited long-term efficacy.

Purpose of the Study:

  • To review the diagnostic criteria and treatment options for primary hyperparathyroidism.
  • To emphasize the role of surgery as the definitive treatment.

Main Methods:

  • Biochemical confirmation of diagnosis.
  • Review of medical and surgical treatment outcomes.

Main Results:

  • Surgery demonstrates an exceptionally high success rate.
  • Minimally invasive surgical techniques are increasingly accepted and effective.

Related Experiment Videos

  • Pharmacologic agents and hydration provide only temporary calcium reduction.

    • Conclusions:

    • Surgical resection is the recommended treatment for most primary hyperparathyroidism patients.
    • The combination of high efficacy, low morbidity, and advanced surgical techniques supports surgical intervention.